Changing a Nation: The Systems-Thinking Playbook for Outsiders

In this conversation, Tania de Jong explains how she and her husband helped make Australia the first country to legalize MDMA and psilocybin for psychiatric use. Because they were outsiders without medical or pharmaceutical backgrounds, they avoided the bureaucratic traps that usually stall advocacy efforts. Their success came from a methodical, high-intensity systems approach that mapped the entire chain of regulatory change, from finding leverage points to managing political fallout. For any entrepreneur or change-maker trying to move a stagnant system, this conversation provides a blueprint for turning impossible barriers into competitive advantages. By focusing on the risk of doing nothing, they forced regulators to face the systemic costs of the status quo.

The Hidden Cost of the Wait and See Approach

Most advocacy movements fail because they play by the rules of an incumbent system designed to prioritize caution over results. De Jong and her team flipped this by reframing the debate. Instead of just presenting data on why a drug works, they forced regulators to account for the risk of doing nothing. By pointing to the avoidable loss of life among patients who had exhausted all other treatments, they shifted the burden of proof from the advocates to the regulators.

"One of the arguments that was really important for the therapeutic goods administration was there's a risk to not doing anything so if you don't do anything if you don't reschedule these medicines that's actually a risk because patients who've tried everything like franco might end up taking their own lives and that would be tragic."

-- Tania de Jong

This is a classic example of systems thinking. By identifying the moral and economic cost of the status quo, they turned the regulator's own mandate to protect public health against the inertia of the system.

Why the Obvious Fix Makes Things Worse

De Jong noted that their biggest obstacles were often the vested interests of incumbents, including researchers who preferred indefinite, low-impact study cycles over clinical implementation. When De Jong and her husband pushed for faster, real-world application, they faced intense personal and professional hostility.

The lesson is that when you try to accelerate a system, you will trigger a defensive response. Most teams see this pushback as a sign to stop. De Jong’s team treated it as a signal that they were hitting the right leverage points. They realized that their lack of institutional pedigree was an asset because it allowed them to ignore the mentality that keeps established experts from challenging the status quo.

"There was a lot of conflict with researchers saying well you know we need to research for another five or 10 or more years and we're arguing but there's patients out there who are gonna take their own lives if they don't get other solutions to their mental health conditions."

-- Tania de Jong

The 18-Month Payoff Nobody Wants to Wait For

The most effective part of their campaign was the focus on integration as the product, rather than the medicine itself. By training over 750 clinicians and establishing a registry at the Australian National University to collect real-world evidence, they created a feedback loop that continues to validate their work. This is the delayed payoff that most campaigns ignore. They built the infrastructure for success long before the regulatory win was secured.

This required patience that most teams lack. By funding the data collection independently, they ensured the system had to acknowledge the high remission rates of 60 to 80 percent compared to the 10 to 15 percent seen in conventional treatments. They did not just win a vote; they built a self-sustaining system that makes reversing the decision difficult.

Key Action Items

• Map the Risk of Doing Nothing: Identify the systemic costs of the current status quo. Use this to shift the burden of proof away from your proposed solution. (Immediate)
• Build the Infrastructure Before the Win: Do not wait for permission to start training your workforce or gathering data. Create the operational templates that make adoption inevitable once the barrier is removed. (Over the next 6 to 12 months)
• Recruit Celebrity Allies for Credibility: Use high-profile experts like David Nutt to provide the scientific weight needed to open doors, but ensure you have real world stories to provide emotional urgency. (Over the next quarter)
• Expect and Plan for the Outsider Backlash: If you challenge a status quo, you will be attacked. Build a support network for your team to handle the emotional toll, and recognize that personal attacks are often a sign that your strategy is working. (Ongoing)
• Focus on Integration, Not Just the Fix: Whether in medicine or business, the catalyst is only the start. Invest in the support systems that ensure the change sticks. This creates a lasting moat that short-term competitors cannot replicate. (12 to 18 months)